EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interconnections between the Gut Microbiome and Alzheimer’s Disease: Mechanisms and Therapeutic Potential

Ahmad M Sait iD, Philip J R Day iD

International Journal of Molecular Sciences · 07.08.2024 · 25 (16) · 8619

DOI: 10.3390/ijms25168619 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.08.2024. Verfasst von Ahmad M Sait und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory Science, Faculty of Applied Medical Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BBSRC, EPSRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a neurodegenerative disease that is known to accumulate amyloid-β (Aβ) and tau protein. Clinical studies have not identified pathogenesis mechanisms or produced an effective cure for AD. The Aβ monoclonal antibody lecanemab reduces Aβ plaque formation for the treatment of AD, but more studies are required to increase the effectiveness of drugs to reduce cognitive decline. The lack of AD therapy targets and evidence of an association with an acute neuroinflammatory response caused by several bacteria and viruses in some individuals has led to the establishment of the infection hypothesis during the last 10 years. How pathogens cross the blood–brain barrier is highly topical and is seen to be pivotal in proving the hypothesis. This review summarizes the possible role of the gut microbiome in the pathogenesis of AD and feasible therapeutic approaches and current research limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeHumansAnimalsAmyloid beta-PeptidesBlood-Brain Barriertau Proteins

Stichwörter der Autor:innen

Alzheimer’s disease (AD)gut microbiomelipopolysaccharide (LPS)short-chain fatty acids (SCFAs)

Substanzen

Amyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Medical Laboratory Science, Faculty of Applied Medical Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Regenerative Medicine Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
  • Department of Medicine, University of Cape Town, Cape Town 7925, South Africa.

ORCID-Profile: Ahmad M Sait, Philip J R Day

Förderung

  • BBSRC
  • EPSRC

Zitieren

APA

Sait, A. M., & Day, P. J. R. (2024). Interconnections between the Gut Microbiome and Alzheimer’s Disease: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences, 25(16), 8619. https://doi.org/10.3390/ijms25168619

Vancouver

Sait AM, Day PJR. Interconnections between the Gut Microbiome and Alzheimer’s Disease: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 2024;25(16):8619. doi:10.3390/ijms25168619

BibTeX
@article{Sait2024,
  author = {Sait, Ahmad M and Day, Philip J R},
  title = {Interconnections between the Gut Microbiome and Alzheimer’s Disease: Mechanisms and Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {16},
  pages = {8619},
  doi = {10.3390/ijms25168619}
}
Kostenlos starten →